2308 related articles for article (PubMed ID: 2832438)
41. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
Kekkonen R; Lähteenmäki P; Luukkainen T; Tuominen J
Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
[TBL] [Abstract][Full Text] [Related]
42. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
[TBL] [Abstract][Full Text] [Related]
43. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
Gaillard RC; Herrmann W
Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522
[TBL] [Abstract][Full Text] [Related]
44. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe.
Mais V; Kazer RR; Cetel NS; Rivier J; Vale W; Yen SS
J Clin Endocrinol Metab; 1986 Jun; 62(6):1250-5. PubMed ID: 3084538
[TBL] [Abstract][Full Text] [Related]
45. Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle.
Fluker MR; Marshall LA; Monroe SE; Jaffe RB
J Clin Endocrinol Metab; 1991 Apr; 72(4):912-9. PubMed ID: 2005218
[TBL] [Abstract][Full Text] [Related]
46. Effects of different gonadotropin pulse frequencies on corpus luteum function during the menstrual cycle of rhesus monkeys.
Hutchison JS; Nelson PB; Zeleznik AJ
Endocrinology; 1986 Nov; 119(5):1964-71. PubMed ID: 3533519
[TBL] [Abstract][Full Text] [Related]
47. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
de Kretser DM; Burger HG; Dumpys R
J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
[TBL] [Abstract][Full Text] [Related]
48. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
Sherman BM; Chapler FK; Crickard K; Wycoff D
J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
[TBL] [Abstract][Full Text] [Related]
49. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
50. Estrogen induces premature luteal regression in rhesus monkeys during spontaneous menstrual cycles, but not in cycles driven by exogenous gonadotropin-releasing hormone.
Hutchison JS; Kubik CJ; Nelson PB; Zeleznik AJ
Endocrinology; 1987 Aug; 121(2):466-74. PubMed ID: 3297646
[TBL] [Abstract][Full Text] [Related]
51. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
[TBL] [Abstract][Full Text] [Related]
52. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL; Wang CF; Yen SS
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
Nillius SJ; Bergquist C; Wide L
Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
[TBL] [Abstract][Full Text] [Related]
54. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
Niaraki MA; Moghissi KS; Borin K
Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
[TBL] [Abstract][Full Text] [Related]
55. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
[TBL] [Abstract][Full Text] [Related]
56. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
[TBL] [Abstract][Full Text] [Related]
57. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
58. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
[TBL] [Abstract][Full Text] [Related]
59. Corpus luteum insufficiency induced by a rapid gonadotropin-releasing hormone-induced gonadotropin secretion pattern in the follicular phase.
Soules MR; Clifton DK; Bremner WJ; Steiner RA
J Clin Endocrinol Metab; 1987 Sep; 65(3):457-64. PubMed ID: 3114301
[TBL] [Abstract][Full Text] [Related]
60. [Pulsatile secretion of ovarian steroids in the mid-luteal phase of the menstrual cycle].
Kajimura H
Nihon Naibunpi Gakkai Zasshi; 1990 Feb; 66(2):134-44. PubMed ID: 2110081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]